Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients

The COVID-19 pandemic has prompted an international effort to develop and repurpose medications and procedures to effectively combat the disease. Several groups have focused on the potential treatment utility of angiotensin-converting–enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Care Manag Sci
Main Authors: Bertsimas, Dimitris, Borenstein, Alison, Mingardi, Luca, Nohadani, Omid, Orfanoudaki, Agni, Stellato, Bartolomeo, Wiberg, Holly, Sarin, Pankaj, Varelmann, Dirk J., Estrada, Vicente, Macaya, Carlos, Gil, Iván J. Núñez
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958102/
https://ncbi.nlm.nih.gov/pubmed/33721153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10729-021-09545-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados